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Abstract
In this review of a collected series of patients undergoing hepatic resection for colorectal
metastases, 100 patients were found to have survived greater than five years from the time of
resection. Of these 100 long-term survivors, 71 remain disease-free through the last follow-up, 19
recurred prior to five years, and ten recurred after five years. Patient characteristics that may have
contributed to survival were examined. Procedures performed included five trisegmentectomies,
32 lobectomies, 16 left lateral segmentectomies, and 45 wedge resections. The margin of resection
was recorded in 27 patients, one of whom had a positive margin, nine of whom had a less than or
equal to l-cm margin, and 17 of whom had a greater than 1-cm margin. Eighty-one patients had a
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solitary metastasis to the liver, 11 patients had two metastases, one patient had three metastases,
and four patients had four metastases. Thirty patients had Stage C primary carcinoma, 40 had
Stage B primary carcinoma, and one had Stage A primary carcinoma. The disease-free interval
from the time of colon resection to the time of liver resection was less than one year in 65 patients,
and greater than one year in 34 patients. Three patients had bilobar metastases. Four of the patients
had extrahepatic disease resected simultaneously with the liver resection. Though several
contraindications to hepatic resection have been proposed in the past, five-year survival has been
found in patients with extrahepatic disease resected simultaneously, patients with bilobar
metastases, patients with multiple metastases, and patients with positive margins. Five-year
disease-free survivors are also present in each of these subsets. It is concluded that five-year
survival is possible in the presence of reported contraindications to resection, and therefore that
the decision to resect the liver must be individualized.
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Liver Metastases are found in over 70 percent of patients dying from carcinoma of the colon
and rectum. The only currently available curative treatment for this condition is hepatic
resection, which has a five-year survival rate of 33 percent.1 Though this treatment has an
impressive survival rate and carries with it a mortality of only about 5 percent,2–5 there
remains a reluctance among physicians to refer patients for this procedure.
The purpose of this report is to discuss long-term survivors from this procedure collected in
a multi-institutional retrospective review. The authors present these data to confirm that
long-term survival is not only possible, but common following hepatic resection for
colorectal metastases, and to examine the characteristics of these five-year survivors to
evaluate the indications and contraindications for this procedure.
Materials and Methods
The methods of data collection have been described in a previous report.1 Briefly, the
records of 859 patients who had undergone hepatic resection for colorectal carcinoma
metastases between 1948 and 1985 were reviewed. Patients who died in the postoperative
period, and patients who had gross tumor left in situ have been excluded. Consecutive
patients from each of 24 recording institutions were reviewed and entered into a single data
base. Approximately two thirds of the patient charts were reviewed by a single author
(K.S.H.), and this author also reviewed all data sheets completed by other authors prior to
entry into the computer.
Five-year survivors included any patient who was known to be alive at five years after liver
resection. One hundred patients met this criteria. Characteristics of these patients were
determined from the computer data base.
In order to look at a comparable group who did not survive five years, a second analysis was
performed using only those patients operated on prior to 1981. This allowed almost
complete five-year follow-up. In order to determine the characteristics by which the
survivors differed significantly from those surviving less than five years, chi-square tests
(for categoric variables) and t tests (for continuous variables such as age) were used.
However, the comparsion of the two groups based on multiple variables requires caution in
interpretation, as significant results can occur by chance when statistical tests are performed
using measurements that may be correlated.
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Results
One hundred patients survived five years after hepatic resection for colorectal metastases
(Table 1). The mean age at the time of liver resection was 56 years, with a range of 18 to 83
years. The male-to-female ratio of the five-year survivors was 1.1 to 1. The length of
survival ranged from 5 to 35+ years.
Disease Status
Of the 100 survivors, 71 (71 percent) remained disease-free through the last follow-up, 19
(19 percent) had recurrences before five years, and ten (10 percent) had recurrences more
than five years after liver resection.
Age at Time of Liver Resection
Ninety-five of the 100 five-year survivors had age recorded at the time of liver resection.
Twelve were less than age 40, 68 were between 40 and 70 years old, and 15 were over 70
years old. The youngest patient was 18 at the time of resection, and he remains alive and
disease-free 13 years later at age 31. The oldest patient was 83 at the time of resection, and
remains alive and disease-free six years later at age 89.
Type of Resection
Ninety-eight of the five-year survivors had the extent of liver resection recorded. Forty-five
had undergone a wedge resection (32 remain disease-free), 26 had undergone a right
lobectomy (22 remain disease-free), six had undergone a left lobectomy (five remain
disease-free), 16 had undergone a left lateral segmentectomy (seven remain disease-free),
and five had undergone a trisegmentectomy (three remain disease-free).
Margin of Resection on Liver Specimen
The margin was recorded in 27 of the 100 five-year survivors. The margin was
histologically positive in one patient (he remains disease-free), was less than or equal to 1
cm in nine patients (4 remain disease-free) and was greater than 1 cm in 17 patients (14
remain disease-free).
Number of Metastases
The number of metastases was recorded as an integer in 96 of the five-year survivors, and
was recorded as “multiple” in only three of the five-year survivors. Eighty-one had a solitary
metastasis resected (58 remain disease-free), 11 had two metastases resected (eight remain
disease-free), one had three metastases resected (he has had a recurrence), and three had four
metastases resected (one remains disease-free).
Distribution of Multiple Metastases
The distribution of metastases was recorded in 16 of the five-year survivors who had
multiple metastases. Thirteen had multiple, unilobar metastases (nine remain disease-free),
and three had multiple, bilobar metastases (two remain disease-free).
Stage of Primary Cancer
Primary cancer stage was recorded in 71 of the five-year survivors. Thirty had mesenteric
node involvement (21 remain disease-free) and 41 did not have mesenteric node
involvement (30 remain disease-free).
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Size of Solitary Metastases
Twelve of the five-year survivors had a solitary metastasis greater than 8 cm in greatest
diameter resected (ten remain disease-free).
Disease-free Interval
The disease-free interval was recorded in 98 of the five-year survivors. Sixty-five had a
disease-free interval less than or equal to one year, and 34 had a disease-free interval greater
than one year.
Comparison of Five-year Survivors with Patients Surviving Less than Five Years (resected
prior to 1981)
By limiting this analysis to those patients resected prior to 1981, the authors were able to
have almost complete five-year follow-up. Three hundred seventy-seven patients had
isolated liver metastases resected prior to 1981. In this group there were 91 five-year
survivors (the other nine five-year survivors were excluded since five were resected in 1981,
and four had resection of both liver and extrahepatic metastases). The actual five-year
survival was 91 of 377 (24 percent). A comparison of these 91 survivors with the 286 who
did not survive five years with respect to number of metastases, mesenteric node
involvement, distribution of multiple metastases, disease-free interval, type of resection,
margin of resection, sex, and age is shown in Table 2.
Nineteen of the five-year survivors had multiple metas-tases, compared with 31 percent of
those who survived less than five years (P < .05). Fifty-one percent of the five-year
survivors but only 36 percent of the nonsurvivors had disease-free intervals of greater than
one year (P < .025). Of the 243 patients for whom the stage of the primary cancer is known,
56 percent of the 63 five-year survivors had negative mesenteric nodes, but only 38 percent
of the nonsurvivors had negative mesenteric nodes (P < .025).
Discussion
Hepatic resection is the only curative treatment currently available for hepatic metastases.
However, physicians remain skeptical as to whether any patient with hepatic metastases can
be cured. In addition, there is a feeling that hepatic resection carries too high a mortality to
be used widely. Many series have addressed the mortality of hepatic resection, and have
consistently found it to be in the range of 5 percent.2–5 This is a very acceptable mortality
for patients who have no alternative treatment.
Many series have also addressed the indications and results of this procedure. Though a five-
year survival of greater than 25 percent2–7 is a generally accepted figure following
resection, there remains a certain degree of skepticism. Many physicians believe that
survival and cure are not possible once a patient has hepatic metastases, and these physicians
feel that the 25 percent survivals recorded are statistical aberrations or the result of statistical
predictions based on short follow-up.
This report presents a collected series of 100 patients who have survived five years after
liver resection. In reviewing the literature, there are only 14 patients reported to survive
greater than five years after the detection of liver metastases without resection,8–9 and only
seven of these were biopsy-proven metastases. The comparison of 100 five-year survivors
from this collected series vs. the 14 five-year survivors without resection in the literature is
very suggestive that hepatic resection does extend survival, and is probably curvative in
certain cases.
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This analysis of the actual survival of those resected prior to 1981 tends to confirm previous
reports. It appears that those patients with a smaller number of metastases, more localized
primary disease, and longer disease-free interval do have a survival advantage. The effect of
margin on survival did not reach statistical significance, but since this factor was only
recorded in 25 percent of patients, it should not be discounted yet. It appears that the
distribution of multiple metastases, sex, age, type of procedure, size of metastases, and
contiguous spread are of less importance in determining prognosis.
An important result of this study is that there are a finite number of five-year survivors in
each of the poor prognosis subgroups. There is one five-year survivor with a positive margin
on the liver specimen, three with bilobar metastases, 30 with stage C primary cancers, and
12 with solitary metastases, 8 cm or greater in diameter. Though survival in the poor
prognosis subgroups is possible, it appears less likely, and decisions regarding surgery must
be individualized.
The authors recommend hepatic resection in any patient with one or two isolated liver
metastases if these can be removed with a low mortality. A l-cm margin should be obtained
if possible. Prognosis will be affected by the stage of the primary cancer, the disease-free
interval, and probably by the margin, but these factors alone should not be regarded as
contraindications to resection. Patients with three or four metastases should be considered
for resection on an individual basis.
Five-year survival following the resection of hepatic metastases is not only possible, but
common. The authors recommend that the prognostic factors be considered in determining
who should undergo this procedure, but since five-year survival does occur despite these
factors, the final decision to resect must be made on an individual basis.
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TABLE 1
Five-Year Survival Following Hepatic Resection for Colorectal Metastases
Characteristics Number Percent*
Number of metastases
  1 81 (81)
  2 11 (11)
  3 1 (1)
  4 3 (3)
  > 4 -
  Multi† 1 (1)
Mesenteric nodes involved from primary cancer
  No 41 (57)
  Yes 30 (42)
Distribution for multiple metastases
  Unilobar 13 (81)
  Bilobar 3 (19)
Disease-free interval
  < 1 year 64 (65)
  > 1 year 34 (35)
Type of resection
  Wedge 45 (46)
  Right lobectomy 26 (27)
  Left lateral segmentectomy 16 (16)
  Left lobectomy 6 (6)
  Trisegmentectomy 5 (5)
Margin in liver specimen
  Positive 1 (4)
  Neg, but < 1 cm 9 (33)
  > 1 cm 17 (63)
*
Percent of patients who had this characteristic.
†
Exact number of metastases not recorded.
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TABLE 2
Actual Five-Year Survival of 377 Patients Undergoing Hepatic Resection for Isolated Colorectal Metastases
Prior to 1981
Characteristics
Survivors/
Total
Actual 5 Year
Survival
(Percent) P
Number of metastases
  1 73/267 27 <.05*
  2 10/55 18
  3 1/18   5
  4 3/11 27
  > 4 0/6 -
Mesenteric nodes involved from primary cancer
  No 35/103 34 < .025
  Yes 28/140 20
Distribution of multiple metastases
  Unilobar 11/60 18 N.S.
  Bilobar 2/23   9
Disease-free interval
  < 1 year 45/228 20 < .025
  > 1 year 46/149 31
Type of resection
  Major 47/187 25 N.S.
  Minor 44/190 23
Margin on liver specimen
  < 1 cm 9/46 20 N.S.
  > 1 cm 14/47 30
Sex
  Male 44/194 23 N.S.
  Female 43/170 25
Age
  < 70 74/315 24 N.S.
  > 70 17/62 27
*
P < .05 for 1 metastasis vs. multiple metastases.
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